SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
Abstract Background This study is aimed to unravel the genetic factors associated with microRNA (miRNA) expression in regulating sex‐determining region Y‐box 2 (SOX2)‐mediated cisplatin resistance in small‐cell lung cancer (SCLC). Methods The relevance of SOX2 expression in SCLC was analyzed in a pa...
| 出版年: | Molecular Genetics & Genomic Medicine |
|---|---|
| 主要な著者: | Fei Cui, Zhe‐xue Hao, Jin Li, Ya‐lei Zhang, Xu‐kai Li, Jian‐xing He |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2020-05-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1002/mgg3.1195 |
類似資料
circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition
著者:: Qianping Liang, 等
出版事項: (2023-05-01)
著者:: Qianping Liang, 等
出版事項: (2023-05-01)
miR-340-5p alleviates the damage effect of LPS on nucleus pulposus cells by negatively regulating the expression of SOX4
著者:: Yuhang Liu, 等
出版事項: (2025-07-01)
著者:: Yuhang Liu, 等
出版事項: (2025-07-01)
Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
著者:: Camile B. Lopes, 等
出版事項: (2018-07-01)
著者:: Camile B. Lopes, 等
出版事項: (2018-07-01)
Cisplatin-based miRNA delivery strategy inspired by the circCPNE1/miR-330-3p pathway for oral squamous cell carcinoma
著者:: Hua-yang Fan, 等
出版事項: (2024-06-01)
著者:: Hua-yang Fan, 等
出版事項: (2024-06-01)
miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
著者:: Nadine De Godoy Torso, 等
出版事項: (2023-11-01)
著者:: Nadine De Godoy Torso, 等
出版事項: (2023-11-01)
miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
著者:: Huang Xin, 等
出版事項: (2023-05-01)
著者:: Huang Xin, 等
出版事項: (2023-05-01)
Down-regulation of circular RNA hsa_circ_0007534 suppresses cell growth by regulating miR-219a-5p/SOX5 axis in osteosarcoma
著者:: Peng Zhang, 等
出版事項: (2021-04-01)
著者:: Peng Zhang, 等
出版事項: (2021-04-01)
Nanotherapeutic interventions to enhance cisplatin sensitivity in ovarian cancer cells
著者:: Disha Mittal, 等
出版事項: (2025-08-01)
著者:: Disha Mittal, 等
出版事項: (2025-08-01)
Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine
著者:: Sheng Li, 等
出版事項: (2023-12-01)
著者:: Sheng Li, 等
出版事項: (2023-12-01)
The MRTF-A/miR-155/SOX1 pathway mediates gastric cancer migration and invasion
著者:: Libin Yin, 等
出版事項: (2020-07-01)
著者:: Libin Yin, 等
出版事項: (2020-07-01)
Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
著者:: Noemi Cerón-Pisa, 等
出版事項: (2022-03-01)
著者:: Noemi Cerón-Pisa, 等
出版事項: (2022-03-01)
Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells
著者:: Yaman Alghamian, 等
出版事項: (2025-03-01)
著者:: Yaman Alghamian, 等
出版事項: (2025-03-01)
WASF3 overexpression affects the expression of circular RNA hsa-circ-0100153, which promotes breast cancer progression by sponging hsa-miR-31, hsa-miR-767-3p, and hsa-miR-935
著者:: Majid Mokhtari, 等
出版事項: (2023-12-01)
著者:: Majid Mokhtari, 等
出版事項: (2023-12-01)
Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
著者:: Linxiang Feng, 等
出版事項: (2023-05-01)
著者:: Linxiang Feng, 等
出版事項: (2023-05-01)
LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2
著者:: Zhining Yang, 等
出版事項: (2023-11-01)
著者:: Zhining Yang, 等
出版事項: (2023-11-01)
Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy
著者:: Ye Tian, 等
出版事項: (2018-06-01)
著者:: Ye Tian, 等
出版事項: (2018-06-01)
Ssc-MiR-21-5p and Ssc-MiR-615 Regulates the Proliferation and Apoptosis of Leydig Cells by Targeting SOX5
著者:: Qi Tang, 等
出版事項: (2022-07-01)
著者:: Qi Tang, 等
出版事項: (2022-07-01)
Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer’s disease
著者:: Siranjeevi Nagaraj, 等
出版事項: (2024-06-01)
著者:: Siranjeevi Nagaraj, 等
出版事項: (2024-06-01)
Longitudinal analysis of hsa-miR-3163, hsa-miR-124-3p, hsa-miR-548c-3p, and hsa-miR-27a-3p as prognostic biomarkers in HIV-infected patients
著者:: Ilker Inanç Balkan, 等
出版事項: (2025-05-01)
著者:: Ilker Inanç Balkan, 等
出版事項: (2025-05-01)
miR‐429 inhibits palmitic acid‐induced apoptosis of porcine subcutaneous preadipocytes by targeting Sox5
著者:: Yonglin Hua, 等
出版事項: (2024-08-01)
著者:: Yonglin Hua, 等
出版事項: (2024-08-01)
Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin
著者:: Szymon Januszyk, 等
出版事項: (2022-05-01)
著者:: Szymon Januszyk, 等
出版事項: (2022-05-01)
Salvianolic acid A improves nerve regeneration and repairs nerve defects in rats with brain injury by downregulating miR‐212‐3p‐mediated SOX7
著者:: Shuai Huang, 等
出版事項: (2023-12-01)
著者:: Shuai Huang, 等
出版事項: (2023-12-01)
Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
著者:: Tatiana Petrova, 等
出版事項: (2024-02-01)
著者:: Tatiana Petrova, 等
出版事項: (2024-02-01)
miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
著者:: Lei Dou, 等
出版事項: (2021-03-01)
著者:: Lei Dou, 等
出版事項: (2021-03-01)
miR-221 activates Sox11 to reduce brain injury after intracerebral hemorrhage via inhibiting neuroinflammation
著者:: Tianyu Liang, 等
出版事項: (2025-08-01)
著者:: Tianyu Liang, 等
出版事項: (2025-08-01)
miR-100 Reverses Cisplatin Resistance in Breast Cancer by Suppressing HAX-1
著者:: Guojun Wu, 等
出版事項: (2018-07-01)
著者:: Guojun Wu, 等
出版事項: (2018-07-01)
hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of <i>PTEN</i> and <i>BIM</i> Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro
著者:: Monika Drobna, 等
出版事項: (2020-05-01)
著者:: Monika Drobna, 等
出版事項: (2020-05-01)
Chemotherapy reprograms miRNA expression profiles in apoptotic extracellular vesicles from medulloblastoma cells, regulating pro- and anti-proliferative effects on recipient drug-naïve cells
著者:: Rosa Mistica C. Ignacio, 等
出版事項: (2025-06-01)
著者:: Rosa Mistica C. Ignacio, 等
出版事項: (2025-06-01)
Tumor-associated macrophage-derived exosome miR-194 confers cisplatin resistance in GC cells
著者:: Yi Zhou, 等
出版事項: (2025-02-01)
著者:: Yi Zhou, 等
出版事項: (2025-02-01)
A preliminary study of the miRNA restitution effect on CNV-induced miRNA downregulation in CAKUT
著者:: Kristina Mitrovic, 等
出版事項: (2024-02-01)
著者:: Kristina Mitrovic, 等
出版事項: (2024-02-01)
The impact of hsa-miR-1972 on the expression of von Willebrand factor in breast cancer progression regulation
著者:: Changjiang Yu, 等
出版事項: (2024-11-01)
著者:: Changjiang Yu, 等
出版事項: (2024-11-01)
Hsa-miR-342-3p and hsa-miR-360 may be the key molecules that promote periodontitis in type 2 diabetes mellitus
著者:: Shaobing Yu, 等
出版事項: (2024-06-01)
著者:: Shaobing Yu, 等
出版事項: (2024-06-01)
SOX2 Regulates Growth, Expression of Basal/Luminal Markers, and Chemotherapy Response in Urothelial Carcinoma
著者:: Nelofar Nargis, 等
出版事項: (2025-06-01)
著者:: Nelofar Nargis, 等
出版事項: (2025-06-01)
Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
著者:: Yonghao Zhan, 等
出版事項: (2020-02-01)
著者:: Yonghao Zhan, 等
出版事項: (2020-02-01)
Serum exosomal hsa-miR-142–5p, hsa-miR-1908–5p, and hsa-miR-450b–5p as candidate biomarkers for recurrent depressive disorder diagnosis and ECT treatment response: A preliminary investigation
著者:: Meng Liu, 等
出版事項: (2025-06-01)
著者:: Meng Liu, 等
出版事項: (2025-06-01)
miR‐155 promotes m6A modification of SOX2 mRNA through targeted regulation of HIF‐1α and delays wound healing in diabetic foot ulcer in vitro models
著者:: Jiarui Peng, 等
出版事項: (2025-01-01)
著者:: Jiarui Peng, 等
出版事項: (2025-01-01)
Bone marrow mesenchymal stem cells-derived exosomal miR-145-5p reduced non-small cell lung cancer cell progression by targeting SOX9
著者:: Wu Yan, 等
出版事項: (2024-07-01)
著者:: Wu Yan, 等
出版事項: (2024-07-01)
LncRNA NEAT1 regulated diabetic retinal epithelial-mesenchymal transition through regulating miR-204/SOX4 axis
著者:: Yang Yang, 等
出版事項: (2021-07-01)
著者:: Yang Yang, 等
出版事項: (2021-07-01)
LncRNA CASC9 promotes cell proliferation and invasion in osteosarcoma through targeting miR-874-3p/SOX12 axis
著者:: Haiyan Qiu, 等
出版事項: (2022-10-01)
著者:: Haiyan Qiu, 等
出版事項: (2022-10-01)
MAP4K4 and WT1 mediate SOX6‐induced cellular senescence by synergistically activating the ATF2–TGFβ2–Smad2/3 signaling pathway in cervical cancer
著者:: Han Zheng, 等
出版事項: (2024-05-01)
著者:: Han Zheng, 等
出版事項: (2024-05-01)
類似資料
-
circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition
著者:: Qianping Liang, 等
出版事項: (2023-05-01) -
miR-340-5p alleviates the damage effect of LPS on nucleus pulposus cells by negatively regulating the expression of SOX4
著者:: Yuhang Liu, 等
出版事項: (2025-07-01) -
Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
著者:: Camile B. Lopes, 等
出版事項: (2018-07-01) -
Cisplatin-based miRNA delivery strategy inspired by the circCPNE1/miR-330-3p pathway for oral squamous cell carcinoma
著者:: Hua-yang Fan, 等
出版事項: (2024-06-01) -
miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
著者:: Nadine De Godoy Torso, 等
出版事項: (2023-11-01)
